Breast Cancer: Current Research
Open Access

Advancing Breast Cancer Immunotherapy: Targeted Treatments and Immune System Modulation

Ashanul Yiu^*

Department of Oncology, University of Gondar, Ethiopia

Received Date: Jun 01, 2024 / Published Date: Jun 27, 2024

Citation: Yiu A (2024) Advancing Breast Cancer Immunotherapy: TargetedTreatments and Immune System Modulation. Breast Can Curr Res 9: 251.

Copyright: © 2024 Yiu A. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

To read the full article Peer-reviewed Article PDF

Breast cancer remains a leading cause of cancer-related deaths among women globally. Despite advances in traditional treatments, challenges persist in achieving long-term remission and minimizing side effects. Immunotherapy, leveraging the body’s immune system to combat cancer, has emerged as a promising avenue for breast cancer treatment. This article reviews the recent advancements in breast cancer immunotherapy, focusing on targeted treatments such as immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, alongside strategies for immune system modulation, including tumor microenvironment modulation, cytokine therapy, and microbiome modulation. The discussion highlights the potential of these therapies, current challenges, and future directions in achieving personalized and effective breast cancer treatment.